MITCHELL DEAN J — SEC insider filings

SEC reporting owner CIK 1199297. 47 insider filings on record with FilingPulse; latest filed 2026-09-24.

Transaction summary — filings shown

Covers all 47 filings on record, filed 2020-10-01 to 2026-09-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Praxis Precision Medicines, Inc. (PRAX)Director92 legs · 75,000 sh · $87,002—13
PRECIGEN, INC. (PGEN)Director101 leg · 25,000 sh · $35,250—22
ImmunoGen, Inc. (IMGN)Director17——36
Theravance Biopharma, Inc. (TBPH)Director7——23
Kinnate Biopharma Inc. (KNTE)Director4——7

Insider filings — MITCHELL DEAN J

FiledFormIssuerReported transactionsSource
2026-09-244Theravance Biopharma, Inc. (TBPH)Disposition to issuer (D): 91,204 · Disposition to issuer (D): 6,009 · Disposition to issuer (D): 6,000 (derivative) · Disposition to issuer (D): 6,000 (derivative) · Disposition to issuer (D): 6,000 (derivative) · Disposition to issuer (D): 6,000 (derivative) · +5 moreEDGAR
2026-06-164Theravance Biopharma, Inc. (TBPH)Grant/award (A): 6,009 @ $0 · Grant/award (A): 13,398 (derivative) @ $0EDGAR
2026-06-124Praxis Precision Medicines, Inc. (PRAX)Grant/award (A): 1,371 @ $0 · Grant/award (A): 648 (derivative) @ $0EDGAR
2025-09-254Praxis Precision Medicines, Inc. (PRAX)Option exercise (M): 1,932 @ $14.36 · Option exercise (M): 8,566 @ $44.25 · Option exercise (M): 1,753 @ $44.04 · Option exercise (M): 1,932 (derivative) @ $0 · Option exercise (M): 8,566 (derivative) @ $0 · Option exercise (M): 1,753 (derivative) @ $0EDGAR
2025-06-274Praxis Precision Medicines, Inc. (PRAX)Grant/award (A): 10,520 (derivative) @ $0EDGAR
2025-05-214Theravance Biopharma, Inc. (TBPH)Grant/award (A): 10,649 @ $0 · Grant/award (A): 24,258 (derivative) @ $0EDGAR
2024-06-064Praxis Precision Medicines, Inc. (PRAX)Grant/award (A): 8,566 (derivative) @ $0EDGAR
2024-05-104Theravance Biopharma, Inc. (TBPH)Grant/award (A): 10,537 @ $0 · Grant/award (A): 23,576 (derivative) @ $0EDGAR
2024-04-054Kinnate Biopharma Inc. (KNTE)Disposition to issuer (D): 121,503 (derivative) · Disposition to issuer (D): 20,250 (derivative) · Disposition to issuer (D): 20,250 (derivative) · Disposition to issuer (D): 25,000 (derivative)EDGAR
2024-03-184PRECIGEN, INC. (PGEN)Grant/award (A): 39,510 @ $1.43 · Grant/award (A): 87,412 (derivative) @ $0 · Grant/award (A): 101,626 (derivative) @ $0EDGAR
2024-03-124PRECIGEN, INC. (PGEN)Option exercise (M): 106,837 · Option exercise (M): 106,837 (derivative) @ $0EDGAR
2024-02-124ImmunoGen, Inc. (IMGN)Disposition to issuer (D): 103,000 · Disposition to issuer (D): 13,090 (derivative) · Disposition to issuer (D): 142,667 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 18,000 (derivative) · +3 moreEDGAR
2023-12-194/AImmunoGen, Inc. (IMGN)Option exercise (M): 10,000 @ $14.70EDGAR
2023-09-264ImmunoGen, Inc. (IMGN)Option exercise (M): 10,000 @ $14.70 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2023-09-254PRECIGEN, INC. (PGEN)Purchase (P): 25,000 @ $1.41EDGAR
2023-06-164ImmunoGen, Inc. (IMGN)Grant/award (A): 13,090 (derivative) @ $0 · Grant/award (A): 19,597 (derivative) @ $0EDGAR
2023-06-144Praxis Precision Medicines, Inc. (PRAX)Grant/award (A): 28,981 (derivative) @ $0EDGAR
2023-06-134Kinnate Biopharma Inc. (KNTE)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2023-05-044Theravance Biopharma, Inc. (TBPH)Grant/award (A): 9,132 @ $0 · Grant/award (A): 22,044 (derivative) @ $0EDGAR
2023-03-274Praxis Precision Medicines, Inc. (PRAX)Purchase (P): 50,000 @ $0.84EDGAR
2023-03-134PRECIGEN, INC. (PGEN)Grant/award (A): 48,290 @ $1.17 · Grant/award (A): 106,837 (derivative) @ $0 · Grant/award (A): 125,489 (derivative) @ $0EDGAR
2023-02-244PRECIGEN, INC. (PGEN)Option exercise (M): 61,576 · Option exercise (M): 61,576 (derivative) @ $0EDGAR
2023-01-044ImmunoGen, Inc. (IMGN)Grant/award (A): 3,024 (derivative) @ $0EDGAR
2022-10-044ImmunoGen, Inc. (IMGN)Grant/award (A): 3,138 (derivative) @ $0EDGAR
2022-07-054ImmunoGen, Inc. (IMGN)Grant/award (A): 3,333 (derivative) @ $0EDGAR
2022-06-174ImmunoGen, Inc. (IMGN)Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 44,000 (derivative) @ $3.37EDGAR
2022-06-154Kinnate Biopharma Inc. (KNTE)Grant/award (A): 20,250 (derivative) @ $0EDGAR
2022-06-094Praxis Precision Medicines, Inc. (PRAX)Purchase (P): 25,000 @ $1.81EDGAR
2022-05-274Praxis Precision Medicines, Inc. (PRAX)Grant/award (A): 22,753 (derivative) @ $0EDGAR
2022-04-284Theravance Biopharma, Inc. (TBPH)Grant/award (A): 9,852 @ $0 · Grant/award (A): 28,000 (derivative) @ $0EDGAR
2022-04-044ImmunoGen, Inc. (IMGN)Grant/award (A): 3,151 (derivative) @ $0EDGAR
2022-03-294PRECIGEN, INC. (PGEN)Option exercise (M): 16,212 · Option exercise (M): 16,212 (derivative) @ $0EDGAR
2022-02-244PRECIGEN, INC. (PGEN)Grant/award (A): 27,832 @ $2.03 · Grant/award (A): 61,576 (derivative) @ $0 · Grant/award (A): 83,189 (derivative) @ $0EDGAR
2022-01-044ImmunoGen, Inc. (IMGN)Grant/award (A): 1,819 (derivative) @ $0EDGAR
2021-10-014ImmunoGen, Inc. (IMGN)Grant/award (A): 2,380 (derivative) @ $0EDGAR
2021-09-034ImmunoGen, Inc. (IMGN)Option exercise (M): 5,000 @ $1.84 · Option exercise (M): 10,000 @ $4.64 · Option exercise (M): 18,000 @ $2.10 · Option exercise (M): 50,000 @ $4.56 · Option exercise (M): 5,000 (derivative) @ $1.84 · Option exercise (M): 10,000 (derivative) @ $4.64 · +2 moreEDGAR
2021-07-024ImmunoGen, Inc. (IMGN)Grant/award (A): 2,048 (derivative) @ $0EDGAR
2021-06-174ImmunoGen, Inc. (IMGN)Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 44,000 (derivative) @ $6.77EDGAR
2021-06-144Kinnate Biopharma Inc. (KNTE)Grant/award (A): 20,250 (derivative) @ $0EDGAR
2021-06-094Praxis Precision Medicines, Inc. (PRAX)Grant/award (A): 22,343 (derivative) @ $0EDGAR
2021-04-294Theravance Biopharma, Inc. (TBPH)Grant/award (A): 9,828 @ $0 · Grant/award (A): 6,000 (derivative) @ $0EDGAR
2021-04-024ImmunoGen, Inc. (IMGN)Grant/award (A): 1,666 (derivative) @ $0EDGAR
2021-03-294PRECIGEN, INC. (PGEN)Grant/award (A): 7,328 @ $7.71 · Grant/award (A): 16,212 (derivative) @ $0 · Grant/award (A): 22,107 (derivative) @ $0EDGAR
2021-03-164PRECIGEN, INC. (PGEN)Option exercise (M): 62,189 · Option exercise (M): 62,189 (derivative) @ $0EDGAR
2021-03-054PRECIGEN, INC. (PGEN)Option exercise (M): 2,968 @ $5.69 · Option exercise (M): 2,968 (derivative) @ $0EDGAR
2021-01-044ImmunoGen, Inc. (IMGN)Grant/award (A): 2,093 (derivative) @ $0EDGAR
2020-10-014ImmunoGen, Inc. (IMGN)Grant/award (A): 3,750 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1199297 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs